What You Should Know:
– Cognizant (Nasdaq: CTSH) announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for Medidata’s life sciences clients and expand the strategic alliance partnership.
– Over the years, the companies have partnered to deliver a comprehensive framework supporting life sciences clients, emphasizing customer success, patient service desk, implementation, engineering, integrations, and user acceptance testing services using Medidata’s clinical platform and solutions.
Cognizant and Medidata: Transforming Clinical Research Through AI-Powered Innovation
Cognizant (Nasdaq: CTSH) engineers modern businesses by helping clients modernize technology, reimagine processes, and transform experiences to stay ahead in a fast-changing world. In a renewed multi-year collaboration, Cognizant and Medidata aim to enhance responsiveness and improve user satisfaction for life sciences organizations relying on Medidata’s technology services for clinical trial development.
· Dedicated Medidata Platform Support: Cognizant provides a specialized team of Medidata Platform experts to assist pharmaceutical, biotech, medical device, and contract research organizations, as well as patients using Medidata services. This support maximizes Medidata’s value for life sciences clients, improving the overall user experience and enabling clients to focus on clinical trial development and patient outcomes.
· AI-Driven Clinical Trial Acceleration: The partnership expands access to Medidata’s AI-powered technologies, including Medidata Clinical Data Studio, Medidata Health Record Connect, and the myMedidata patient portal. These solutions streamline research and development by enhancing patient, site, and data experiences.
· Operational Excellence and Data Modernization: As a top Global Medidata Strategic Alliance Partner, Cognizant leverages its extensive network of Medidata Certified Services Professionals to help life sciences organizations modernize clinical operations and data management.
“Our partnership with Cognizant represents a shared commitment to transforming clinical research through innovation and expertise,” said Janet Butler, EVP, Head of Global Sales, Medidata. “By combining Medidata’s advanced AI-driven technologies with Cognizant’s deep industry knowledge and operational excellence, we support life sciences organizations in streamlining their R&D efforts, deriving actionable insights from complex data, and ultimately bringing life-changing therapies to patients more efficiently.”
